Impact of multiple medical interventions on mortality, length of hospital stay and reepithelialization time in Toxic Epidermal Necrolysis, Steven-Johnsons Syndrome, and TEN/SJS Overlap – Metanalysis and metaregression of observational studies-Reference-Cited by-同舟云学术

Impact of multiple medical interventions on mortality, length of hospital stay and reepithelialization time in Toxic Epidermal Necrolysis, Steven-Johnsons Syndrome, and TEN/SJS Overlap – Metanalysis and metaregression of observational studies

Published:2021-11 Issue: Volume: Page:
ISSN:0305-4179
Container-title:Burns
language:en
Short-container-title:Burns

Author:

Krajewski A.,Maciejewska-Markiewicz D.,Jakubczyk K.,Markowska M.,Strużyna J.,Mądry R.,Mazurek M.,Skonieczna-Żydecka K.

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine,General Medicine,Surgery

Reference55 articles.

1. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016;Creamer;J Plast Reconstr Aesthet Surg,2016

2. British Association of Dermatologists guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in children and young people;McPherson;Br J Dermatol.,2018

3. Etanercept therapy for toxic epidermal necrolysis;Paradisi;J Am Acad Dermatol,2014

4. Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States;Micheletti;J Invest Dermatol,2018

5. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience;Nizamoglu;Burns,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study;Frontiers in Immunology;2024-08-07

2. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

3. High risk and low prevalence diseases: Stevens Johnson syndrome and toxic epidermal necrolysis;The American Journal of Emergency Medicine;2024-07

4. Hyperuricemia – consequences of not initiating therapy. Benefits and drawbacks of treatment;Rheumatology;2024-07-01

5. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome;Pediatric Allergy, Immunology, and Pulmonology;2024-03-01